Literature DB >> 12684897

Comparative values of catecholamines and metabolites for the diagnosis of neuroblastoma.

Maud Monsaingeon1, Yves Perel, Guy Simonnet, Jean-Benoît Corcuff.   

Abstract

UNLABELLED: In order to diagnose neuroblastomas, we assayed the three adrenal hormones and five of their metabolites by high-performance liquid chromatography followed by electrochemical detection in urine samples of 395 children with tumours of unknown nature (including 29 neuroblastomas). The analytes (expressed as analyte/creatinine ratios) performances were determined by calculating the related sensitivity and specificity and receiver operating characteristics curves within the different age groups. Normetanephrine (NME), vanillylmandelic and homovanillic acids (VMA, HVA) were the best analytes. Calculated optimal thresholds (best specificity/sensitivity couples) of these analytes minimised the number of false-positive diagnosis.
CONCLUSION: combined determination of normetanephrine with vanillylmandelic acid (0-1 year) or homovanillic acid (1-5 years and 5-10 years) further enhanced the diagnostic power up to 100% sensitivity and specificity of the testing depending on the age group. Plotting individual levels (normetanephrine versus vanillylmandelic acid or homovanillic acid) allowed a rapid visual analysis that would have missed only one small low grade non-secreting tumour.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684897     DOI: 10.1007/s00431-003-1175-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  18 in total

1.  Methylated catecholamine metabolites for diagnosis of neuroblastoma.

Authors:  M Candito; A Thyss; M Albertini; A Deville; S Politano; R Mariani; P Chambon
Journal:  Med Pediatr Oncol       Date:  1992

2.  Mass screening for neuroblastoma targeting children age 14 months in Sapporo City: a preliminary report.

Authors:  M Nishi; H Miyake; T Takeda; J Hanai; Y Kikuchi; T Hirama
Journal:  Cancer       Date:  1998-05-15       Impact factor: 6.860

Review 3.  Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.

Authors:  M H Zweig; G Campbell
Journal:  Clin Chem       Date:  1993-04       Impact factor: 8.327

4.  Biosynthesis and storage of catecholamines in pheochromocytoma and neuroblastoma cells.

Authors:  T Itoh; K Omori
Journal:  J Lab Clin Med       Date:  1973-06

5.  Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992.

Authors:  S J Cotterill; A D Pearson; J Pritchard; A B Foot; B Roald; J A Kohler; J Imeson
Journal:  Eur J Cancer       Date:  2000-05       Impact factor: 9.162

6.  Interpretation of random urinary catecholamines and their metabolites in neuroblastoma.

Authors:  A O'Meara; W Tormey; R J FitzGerald; M Fitzgibbon; D Kenny
Journal:  Acta Paediatr       Date:  1994-01       Impact factor: 2.299

Review 7.  Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

Authors:  G M Brodeur; J Pritchard; F Berthold; N L Carlsen; V Castel; R P Castelberry; B De Bernardi; A E Evans; M Favrot; F Hedborg
Journal:  J Clin Oncol       Date:  1993-08       Impact factor: 44.544

8.  Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma.

Authors:  M Tuchman; M L Ramnaraine; W G Woods; W Krivit
Journal:  Pediatrics       Date:  1987-02       Impact factor: 7.124

9.  Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma.

Authors:  W E Laug; S E Siegel; K N Shaw; B Landing; J Baptista; M Gutenstein
Journal:  Pediatrics       Date:  1978-07       Impact factor: 7.124

10.  DOPA metabolism in neuroblastoma.

Authors:  L Helson; G A Johnson; R Smith
Journal:  Med Pediatr Oncol       Date:  1980
View more
  4 in total

Review 1.  Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma.

Authors:  Graeme Eisenhofer; Mirko Peitzsch; Nicole Bechmann; Angela Huebner
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-26       Impact factor: 6.055

2.  Prognostic value of ferritin, neuron-specific enolase, lactate dehydrogenase, and urinary and plasmatic catecholamine metabolites in children with neuroblastoma.

Authors:  Giuliana Cangemi; Giorgio Reggiardo; Sebastiano Barco; Laura Barbagallo; Massimo Conte; Paolo D'Angelo; Maurizio Bianchi; Claudio Favre; Barbara Galleni; Giovanni Melioli; Riccardo Haupt; Alberto Garaventa; Maria V Corrias
Journal:  Onco Targets Ther       Date:  2012-11-30       Impact factor: 4.147

Review 3.  Urinary sampling for 5HIAA and metanephrines determination: revisiting the recommendations.

Authors:  Jean-Benoît Corcuff; Laurence Chardon; Ines El Hajji Ridah; Julie Brossaud
Journal:  Endocr Connect       Date:  2017-05-31       Impact factor: 3.335

4.  Application of an LC-MS/MS Method for the Simultaneous Quantification of Homovanillic Acid and Vanillylmandelic Acid for the Diagnosis and Follow-Up of Neuroblastoma in 357 Patients.

Authors:  Narae Hwang; Eunbin Chong; Hyeonju Oh; Hee Won Cho; Ji Won Lee; Ki Woong Sung; Soo-Youn Lee
Journal:  Molecules       Date:  2021-06-07       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.